NovoCure (NVCR) Interest & Investment Income (2021 - 2026)
NovoCure recorded quarterly Interest & Investment Income of -$1.8 million in Q1 2026, down 227.63% quarter-over-quarter from -$561000.0 in Q4 2025, and down 124.28% year-over-year from $7.6 million in Q1 2025.
NovoCure's Interest & Investment Income history runs 6 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 124.28% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at $8.1 million (down 78.01% YoY), while the FY2025 annual figure was $17.6 million, down 55.38% from the prior year.
- Interest & Investment Income came in at -$1.8 million for Q1 2026 at NovoCure, down from -$561000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $18.5 million in Q4 2022 to a low of -$1.8 million in Q1 2026.
- A 5-year average of $7.7 million and a median of $8.8 million in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 739.45% in 2023 and slumped 124.28% in 2026, its largest moves.
- NovoCure's Interest & Investment Income stood at $18.5 million in 2022, then fell by 28.87% to $13.2 million in 2023, then slumped by 38.57% to $8.1 million in 2024, then slumped by 106.93% to -$561000.0 in 2025, then slumped by 227.63% to -$1.8 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$1.8 million, -$561000.0, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | -1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.84 Mn |
| Dec 31, 2025 | -561,000.00 |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Mar 31, 2025 | 7.57 Mn |
| Dec 31, 2024 | 8.10 Mn |
| Sep 30, 2024 | 10.51 Mn |
| Jun 30, 2024 | 10.85 Mn |
| Mar 31, 2024 | 9.88 Mn |
| Dec 31, 2023 | 13.18 Mn |
| Sep 30, 2023 | 10.02 Mn |
| Jun 30, 2023 | 8.76 Mn |
| Mar 31, 2023 | 9.17 Mn |
| Dec 31, 2022 | 18.53 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Dec 31, 2021 | 6.66 Mn |
| Sep 30, 2021 | -1.98 Mn |